A practical cost-effective management strategy for gallstone pancreatitis Journal Article

Authors: Tabone, L. E.; Conlon, M.; Fernando, E.; Yi, S.; Sarker, S.; Fisichella, P. M.; Luchette, F. A.
Article Title: A practical cost-effective management strategy for gallstone pancreatitis
Abstract: BACKGROUND: The purpose of this study was to evaluate the outcomes of various surgeon strategies used to evaluate and treat common duct stones (CDSs) in patients presenting with mild to moderate gallstone pancreatitis (GP). METHODS: We performed a retrospective review of patients admitted for mild to moderate GP. Data variables included laboratory values and radiology images, indications for and findings of intraoperative cholangiogram (IOC) and endoscopic retrograde cholangiopancreatography (ERCP), length of stay (LOS), and hospital charges. Data were stratified by 2 different management strategies: preoperative ERCP and then laparoscopic cholecystectomy (LC) or LC with IOC followed by selective postoperative ERCP. RESULTS: During this time period, 80 patients met the study criteria, 56 were treated by LC with IOC, and 24 had a preoperative ERCP performed. The incidence of CDS was 33% (n = 26). The presence of CDSs correlated with an elevated total bilirubin at admission (CDSs 3.5 mg/dL vs 2.1 mg/dL no CDSs, P .01) and 24 hours after admission (CDS 3.2 mg/dL vs 1.5 mg/dL no CDS, P .01). Patients who had an IOC compared with those who had preoperative ERCP had a shorter LOS (4.6 vs 5.9 days, P = .04) and lower hospital charges (US $28,510 vs US $38,620; P .01). CONCLUSIONS: Elevated total bilirubin at admission and 24 hours after admission may predict a patient's risk for CDS. We found that the management of uncomplicated GP with early LC and IOC results in decreased LOS and total hospital charges when compared with preoperative ERCP.
Journal Title: American Journal of Surgery
Volume: 206
Issue: 4
ISSN: 1879-1883; 0002-9610
Publisher: Elsevier Inc  
Journal Place: United States
Date Published: 2013
Start Page: 472
End Page: 477
Language: eng
Notes: CI: Copyright (c) 2013; JID: 0370473; RFM9X3LJ49 (Bilirubin); OTO: NOTNLM; 2012/08/26 [received]; 2012/11/22 [revised]; 2012/12/27 [accepted]; 2013/04/28 [aheadofprint]; ppublish